首页|杏贝止咳颗粒联合头孢克肟治疗慢性支气管炎急性发作的临床研究

杏贝止咳颗粒联合头孢克肟治疗慢性支气管炎急性发作的临床研究

Effect of Xingbei Zhike Granule combined with cefixime in treating acute exacerbation of chronic bronchitis

扫码查看
目的 探究杏贝止咳颗粒联合头孢克肟治疗慢性支气管炎急性发作(AECB)的临床效果.方法 选取海安人民医院 2022 年4 月至2023 年4 月收治的95 例AECB患者,采用随机数表法分为研究组和对照组,对照组采用头孢克肟口服治疗,研究组在此基础上联合杏贝止咳颗粒治疗,2 组均连续治疗 1 周.治疗后,比较 2 组患者临床疗效;记录2 组患者咳嗽、咳痰、喘息改善时间;比较2 组患者治疗前后中医证候(咳嗽、咯痰、喘息、哮鸣)积分;比较2 组患者治疗前后肺功能[第 1 秒用力呼吸容积(FEV1)、第 1 秒用力呼吸容积占用力肺活量之比值(FEV1/FVC)、呼气峰值流速(PEF)];比较 2 组患者治疗前后血清炎性因子[白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、C-反应蛋白(CRP)];统计用药不良反应.结果 治疗后,研究组总有效率[46/48(95.83%)]高于对照组[38/48(80.85%)],差异有统计学意义(P<0.05).治疗后,研究组咳嗽、咳痰、喘息改善时间均短于对照组(P<0.05).治疗后,研究组咳嗽、咯痰、喘息、哮鸣积分低于对照组(P<0.05).治疗后,研究组FEV1、FEV1/FVC、PEF高于对照组(P<0.05).治疗后,研究组IL-6、TNF-α、CRP低于对照组(P<0.05).2 组腹泻、恶心、腹痛发生率比较,差异无统计学意义(P>0.05).结论 杏贝止咳颗粒联合头孢克肟治疗AECB疗效显著,能有效缓解患者临床症状,改善肺功能,减轻炎性反应,且安全性较好.
Objective To explore the clinical effect of Xingbei Zhike Granule combined with cefixime in treating acute exacerbation of chronic bronchitis(AECB).Methods A total of 95 AECB patients admitted to Hai'an People's Hospital from April 2022 to April 2023 were recruited.They were randomly divided into study group and control group.All patients were treated with cefixime orally,and patients in the study group were additionally treated with Xingbei Zhike Granule.Both groups were treated continuously for 1 week.The clinical efficacy of the two groups was assessed.The improvement time of cough,expectoration,and wheezing in the two groups was recorded.The traditional Chinese medicine(TCM)syndrome(cough,expectoration,and wheezing,wheezing sound)scores,lung function including forced expiratory volume in one second(FEV1),ratio of forced expiratory volume in one second to forced vital capacity(FEV1/FVC),and peak expiratory flow(PEF),serum inflammatory factors including interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),and C-reactive protein(CRP)were compared between groups before and after treatment.Adverse drug reactions were counted.Results After treatment,the total effective rate in the study group was significantly higher that of the control group(46/48[95.83%]vs 38/48[80.85%],P<0.05).After treatment,patients in the study group presented significantly shorter time to cough,expectoration,and wheezing,significantly lower TCM syndrome(cough,expectoration,and wheezing,wheezing sound)scores,significantly higher levels of FEV1,FEV1/FVC,and PEF,significantly lower levels of IL-6,TNF-α and CRP than those of control group(all P<0.05).There was no statistical significant difference in the incidence of diarrhea,nausea,and abdominal pain between groups(P>0.05).Conclusion Xingbei Zhike Granule combined with cefixime is effective in the treatment of AECB,which can effectively alleviate the clinical symptoms of patients,improve lung function,reduce inflammatory reaction,and it is good safety.

chronic bronchitisacute exacerbationXingbei Zhike Granulescefiximepulmonary function

崔恒静、吉秋霞

展开 >

226600 江苏省海安市人民医院药剂科

慢性支气管炎 急性发作 杏贝止咳颗粒 头孢克肟 肺功能

2024

河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
年,卷(期):2024.46(7)
  • 17